Chronic Inflammatory Demyelinating Polyneuropathy Clinical Trials 2023
Chronic Inflammatory Demyelinating Polyneuropathy research studies recruiting patients in 2023 need your help. Receive premium care & cutting edge treatments by enrolling in chronic inflammatory demyelinating polyneuropathy clinical trials today.
Popular Filters
Trials for CIDP Patients
Monoclonal Antibodies
Nipocalimab for CIDP
Recruiting0 awardsPhase 2 & 3
Los Angeles, California
This trial is testing nipocalimab, a medicine that helps the immune system, in adults with CIDP who initially respond to it. The goal is to see if it can safely and effectively delay the return of symptoms by blocking harmful immune actions.
Monoclonal Antibodies
SAR445088 for Chronic Inflammatory Demyelinating Polyneuropathy
Recruiting1 awardPhase 2
Orange, California
This trial is testing the efficacy and safety of SAR445088 in CIDP patients. There are three groups of patients: those who are currently being treated with the standard of care (SOC-Treated), those who are refractory to SOC (SOC-Refractory), and those who have never been treated with SOC (SOC-Naive). The secondary objectives are to assess the long-term safety and tolerability of SAR445088 in CIDP patients, as well as the durability of its efficacy over time.
Trials for Chronic Inflammatory Demyelinating Polyradiculoneuropathy Patients
Monoclonal Antibodies
Nipocalimab for CIDP
Recruiting0 awardsPhase 2 & 3
Los Angeles, California
This trial is testing nipocalimab, a medicine that helps the immune system, in adults with CIDP who initially respond to it. The goal is to see if it can safely and effectively delay the return of symptoms by blocking harmful immune actions.
Immunosuppressant
Stem Cell Transplant for Autoimmune Neurological Diseases
Recruiting1 awardPhase 2
Denver, Colorado
This trial tests a combination of strong chemotherapy and an immune-suppressing medicine followed by a stem cell transplant. It targets patients with autoimmune neurological diseases that haven't improved with other treatments. The treatment aims to weaken the immune system to stop it from attacking the nervous system and then helps the body recover by making new blood cells. High-dose chemotherapy followed by a stem cell transplant has been shown to improve various autoimmune diseases.
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.